
-
Reagents
- Flow Cytometry Reagents
-
Western Blotting and Molecular Reagents
- Immunoassay Reagents
-
Single-Cell Multiomics Reagents
- BD® OMICS-Guard Sample Preservation Buffer
- BD® AbSeq Assay
- BD® Single-Cell Multiplexing Kit
- BD Rhapsody™ ATAC-Seq Assays
- BD Rhapsody™ Whole Transcriptome Analysis (WTA) Amplification Kit
- BD Rhapsody™ TCR/BCR Next Multiomic Assays
- BD Rhapsody™ Targeted mRNA Kits
- BD Rhapsody™ Accessory Kits
- BD® OMICS-One Protein Panels
-
Functional Assays
-
Microscopy and Imaging Reagents
-
Cell Preparation and Separation Reagents
-
- BD® OMICS-Guard Sample Preservation Buffer
- BD® AbSeq Assay
- BD® Single-Cell Multiplexing Kit
- BD Rhapsody™ ATAC-Seq Assays
- BD Rhapsody™ Whole Transcriptome Analysis (WTA) Amplification Kit
- BD Rhapsody™ TCR/BCR Next Multiomic Assays
- BD Rhapsody™ Targeted mRNA Kits
- BD Rhapsody™ Accessory Kits
- BD® OMICS-One Protein Panels
- France (English)
-
Change country/language
Old Browser
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current country site or be switched to your country?
BD Pharmingen™ PE Rat Anti-Mouse Active Integrin β7
Clone H3/B7 (also known as H3) (RUO)

Two-color flow cytometric analysis of Active Integrin β7 expression on Mouse lymph node cells. C57BL/6 Mouse lymph node cells were treated with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899), then washed in Hanks' Balanced Salt Solution (HBSS), and preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody (Mouse BD Fc Block™) [Cat. No. 553141]. The cells were then stained in HBSS (Top Plots) or HBSS + Mn2+ (Bottom Plots) with BD OptiBuild™ BV421 Integrin β7 chain antibody (Cat No. 743787), and with either PE Rat IgG2a, κ Isotype Control (Cat. No. 553930/554689; Left Plots) or PE Rat Anti-Mouse Active Integrin β7 antibody (Cat. No. 571202/571203; Right Plots) at 0.5 μg/test. 7-AAD (7-Amino-Actinomycin D) Solution (Cat. No. 559925) was added to the cells right before analysis. The bivariate pseudocolor density plots showing the correlated expression of Active Integrin β7 (or Ig Isotype control staining) versus Integrin β7 chain were derived from gated events with the forward and side light-scatter characteristics of viable (7-AAD-negative) leukocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa™ X-20 Cell Analyzer System and FlowJo™ software. Data shown on this Technical Data Sheet are not lot specific.


Two-color flow cytometric analysis of Active Integrin β7 expression on Mouse lymph node cells. C57BL/6 Mouse lymph node cells were treated with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899), then washed in Hanks' Balanced Salt Solution (HBSS), and preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody (Mouse BD Fc Block™) [Cat. No. 553141]. The cells were then stained in HBSS (Top Plots) or HBSS + Mn2+ (Bottom Plots) with BD OptiBuild™ BV421 Integrin β7 chain antibody (Cat No. 743787), and with either PE Rat IgG2a, κ Isotype Control (Cat. No. 553930/554689; Left Plots) or PE Rat Anti-Mouse Active Integrin β7 antibody (Cat. No. 571202/571203; Right Plots) at 0.5 μg/test. 7-AAD (7-Amino-Actinomycin D) Solution (Cat. No. 559925) was added to the cells right before analysis. The bivariate pseudocolor density plots showing the correlated expression of Active Integrin β7 (or Ig Isotype control staining) versus Integrin β7 chain were derived from gated events with the forward and side light-scatter characteristics of viable (7-AAD-negative) leukocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa™ X-20 Cell Analyzer System and FlowJo™ software. Data shown on this Technical Data Sheet are not lot specific.

Two-color flow cytometric analysis of Active Integrin β7 expression on Mouse lymph node cells. C57BL/6 Mouse lymph node cells were treated with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899), then washed in Hanks' Balanced Salt Solution (HBSS), and preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody (Mouse BD Fc Block™) [Cat. No. 553141]. The cells were then stained in HBSS (Top Plots) or HBSS + Mn2+ (Bottom Plots) with BD OptiBuild™ BV421 Integrin β7 chain antibody (Cat No. 743787), and with either PE Rat IgG2a, κ Isotype Control (Cat. No. 553930/554689; Left Plots) or PE Rat Anti-Mouse Active Integrin β7 antibody (Cat. No. 571202/571203; Right Plots) at 0.5 μg/test. 7-AAD (7-Amino-Actinomycin D) Solution (Cat. No. 559925) was added to the cells right before analysis. The bivariate pseudocolor density plots showing the correlated expression of Active Integrin β7 (or Ig Isotype control staining) versus Integrin β7 chain were derived from gated events with the forward and side light-scatter characteristics of viable (7-AAD-negative) leukocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa™ X-20 Cell Analyzer System and FlowJo™ software. Data shown on this Technical Data Sheet are not lot specific.


BD Pharmingen™ PE Rat Anti-Mouse Active Integrin β7

Regulatory Status Legend
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
Preparation And Storage
Recommended Assay Procedures
BD® CompBeads can be used as surrogates to assess fluorescence spillover (compensation). When fluorochrome conjugated antibodies are bound to BD® CompBeads, they have spectral properties very similar to cells. However, for some fluorochromes there can be small differences in spectral emissions compared to cells, resulting in spillover values that differ when compared to biological controls. It is strongly recommended that when using a reagent for the first time, users compare the spillover on cells and BD® CompBeads to ensure that BD® CompBeads are appropriate for your specific cellular application.
Product Notices
- Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.
- Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
- Since applications vary, each investigator should titrate the reagent to obtain optimal results.
- For fluorochrome spectra and suitable instrument settings, please refer to our Multicolor Flow Cytometry web page at www.bdbiosciences.com/colors.
- An isotype control should be used at the same concentration as the antibody of interest.
- Please refer to http://regdocs.bd.com to access safety data sheets (SDS).
- For U.S. patents that may apply, see bd.com/patents.
Companion Products






The H3 monoclonal antibody specifically recognizes the activated conformational form of the Integrin β7 which is known as Active Integrin β7. Integrin β7 is a 130 kDa single pass type I transmembrane glycoprotein that is encoded by Itgb7 (integrin beta 7). Integrin β7 noncovalently associates with either Integrin α4 or αE chains to form Integrin α4/β7 or Integrin αE/β7 heterodimers. Integrin β7 is activated to an adhesive form within these complexes in response to various stimuli including Mn2+ ions, cytokines, or chemokines. Integrin α4β7, also known as CD49d/β7 or LPAM-1, is expressed on B and T lymphocytes, NK cells and on subsets of thymocytes and bone marrow cells. Activated Integrin α4β7 binds to Mucosal addressin cell adhesion molecule-1 (MAdCAM-1) which acts as a key vascular addressin for intestinal homing. It also binds to CD106 (VCAM-1) expressed on dendritic cells and endothelial cells and the extracellular matrix protein fibronectin which are involved in the adhesion and migration of lymphocytes and some hematopoietic progenitor cells. Integrin αE/β7 (also known as, CD103/β7 or αIEL/β7) is expressed on intestinal intraepithelial lymphocytes (IEL), dendritic epidermal T cells, T regulatory cells, and a subset of CD8+ T cells in lymph nodes and lamina propria. Activated CD103/β7 binds to CD324 (E-Cadherin) which is involved in the homing of lymphocytes to and their retention at intestinal epithelium.

Development References (4)
-
Le Floc'h A, Jalil A, Vergnon I, et al. Alpha E beta 7 integrin interaction with E-cadherin promotes antitumor CTL activity by triggering lytic granule polarization and exocytosis.. J Exp Med. 2007; 204(3):559-70. (Biology). View Reference
-
Nie J, Carpenter AC, Chopp LB, et al. The transcription factor LRF promotes integrin β7 expression by and gut homing of CD8αα+ intraepithelial lymphocyte precursors.. Nat Immunol. 2022; 23(4):594-604. (Biology). View Reference
-
Qi J, Zhang K, Zhang Q, et al. Identification, characterization, and epitope mapping of human monoclonal antibody J19 that specifically recognizes activated integrin α4β7.. J Biol Chem. 2012; 287(19):15749-59. (Biology). View Reference
-
Sato T, Ishihara S, Marui R, Takagi J, Katagiri K. Dissection of α4β7 integrin regulation by Rap1 using novel conformation-specific monoclonal anti-β7 antibodies.. Sci Rep. 2020; 10(1):13221. (Immunogen: Flow cytometry). View Reference
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.